Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Malabar Remedies Ltd
NSE: MALABARREMBSE: 540987Pharma Formulations
₹3,154.80
▲ 59.35 (+1.92%)
Balance Sheet
- FY22: 12,910
- FY23: 14,316
- FY24: 15,801
- FY25: 17,410
- FY26: 19,672
- FY22: 4,741
- FY23: 5,069
- FY24: 6,157
- FY25: 6,443
- FY26: 6,189
- FY22: 23,547
- FY23: 27,020
- FY24: 29,347
- FY25: 37,824
- FY26: 38,682
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Share capital | 606 | 606 | 606 | 606 | 606 |
| Reserves | 12,304 | 13,710 | 15,195 | 16,804 | 19,066 |
| Total equity | 12,910 | 14,316 | 15,801 | 17,410 | 19,672 |
| Borrowings | 4,741 | 5,069 | 6,157 | 6,443 | 6,189 |
| Trade payables | 2,479 | 2,983 | 3,922 | 2,771 | 3,809 |
| Other current liabilities | 1,230 | 973 | 1,580 | 2,723 | 2,796 |
| Other liabilities | 2,187 | 3,679 | 1,887 | 8,477 | 6,216 |
| Total liabilities | 23,547 | 27,020 | 29,347 | 37,824 | 38,682 |
| Net block | 10,566 | 11,363 | 13,595 | 14,881 | 16,776 |
| Capital work in progress | 418 | 536 | 501 | 1,099 | 1,122 |
| Investments | 1,503 | 2,950 | 2,172 | 4,791 | 3,655 |
| Inventories | 2,821 | 3,176 | 3,479 | 6,533 | 5,926 |
| Trade receivables | 3,264 | 4,316 | 3,395 | 5,347 | 5,004 |
| Cash & equivalents | 2,574 | 2,373 | 2,884 | 2,411 | 5,114 |
| Other current assets | 2,400 | 2,306 | 3,322 | 2,763 | 1,086 |
| Total assets | 23,547 | 27,020 | 29,347 | 37,824 | 38,682 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium